Startup CardioCell developing a stem cell-based therapy for chronic heart failure – MedCity

  “San Diego biotech CardioCell seems to be progressing nicely in developing a stem cell-based therapy for chronic heart failure.

The startup is in Phase 2a clinical trials at four U.S. sites for chronic heart failure: Northwestern University, University of Pennsylvania Medical Center, Emory University and Stony Brook University.
It just raised a $1 million equity round, according to a regulatory filing. Its therapies are directed toward chronic heart failure, acute myocardial infarction and peripheral artery disease. Here’s how CEO Sergey Sikora posits the chronic heart failure therapy works:”
http://medcitynews.com/2015/05/cardiocell-stem-cell-chronic-heart-failure/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s